Table 1 Overview of the data sets used in the comparison study
From: Block Forests: random forests for blocks of clinical and omics covariate data
Name | Cancer type | Sample size | Uncensored observations |
|---|---|---|---|
BLCA | Bladder Urothelial Carcinoma | 310 | 32% |
BRCA | Breast Invasive Carcinoma | 863 | 9% |
CESC | Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma | 206 | 15% |
COAD | Colon Adenocarcinoma | 350 | 22% |
ESCA | Esophageal Carcinoma | 121 | 21% |
GBM | Glioblastoma Multiforme | 154 | 73% |
HNSC | Head and Neck Squamous Cell Carcinoma | 411 | 35% |
KIRC | Kidney Renal Clear Cell Carcinoma | 322 | 22% |
KIRP | Kidney Renal Papillary Cell Carcinoma | 249 | 10% |
LGG | Brain Lower Grade Glioma | 454 | 21% |
LIHC | Liver Hepatocellular Carcinoma | 298 | 28% |
LUAD | Lung Adenocarcinoma | 424 | 30% |
LUSC | Lung Squamous Cell Carcinoma | 365 | 39% |
OV | Ovarian Serous Cystadenocarcinoma | 261 | 54% |
PAAD | Pancreatic Adenocarcinoma | 142 | 49% |
PRAD | Prostate Adenocarcinoma | 425 | 2% |
READ | Rectum Adenocarcinoma | 138 | 16% |
SARC | Sarcoma | 183 | 16% |
SKCM | Skin Cutaneous Melanoma | 264 | 25% |
STAD | Stomach Adenocarcinoma | 284 | 27% |
UCEC | Uterine Corpus Endometrial Carcinoma | 503 | 13% |